Archives of Obesity and Metabolism (비만대사연구학술지)

The Study of Obesity and Metabolic Syndrome, KAFM (대한가정의학회 비만대사증후군연구회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Morbid Obese Patient with Comorbidities: Why a Lifestyle Modification is Important

동반 질환을 가진 고도 비만 환자의 증례: 생활습관 교정이 왜 중요한가?

  • Eunjin Shin (Department of Family Medicine, Sanggye-Paik Hospital, College of Medicine, Inje University) ;
  • Seon Yeong Lee (Department of Family Medicine, Sanggye-Paik Hospital, College of Medicine, Inje University)
  • 신은진 (인제대학교 의과대학 상계백병원 가정의학과) ;
  • 이선영 (인제대학교 의과대학 상계백병원 가정의학과)
  • Received : 2023.10.06
  • Accepted : 2023.11.22
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Obesity is a complex multifactorial disease that is associated with various complications, including cardiovascular diseases. The prevalence of obesity among young adult males has increased, and this has increased the prevalence of several comorbidities. This trend was closely linked to lifestyle factors, including heavy drinking, smoking cigarettes, and an imbalanced diet. This emphasized the necessity of lifestyle improvements for effective obesity management. In this case, the comprehensive lifestyle changes and adjuvant medication resulted in weight loss and improvement in several comorbid conditions in a young adult male. The case highlighted the importance of a comprehensive approach to managing obesity. Furthermore, it emphasized the importance of a healthy lifestyle in addressing obesity and its complications.

Keywords

References

  1. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209. https://doi.org/10.1016/S0140-6736(05)67483-1
  2. Brown JD, Buscemi J, Milsom V, Malcolm R, O'Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med 2016;6:339-46. https://doi.org/10.1007/s13142-015-0353-9
  3. Haam JH, Kim BT, Kim EM, et al. Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr 2023;32:121-9. https://doi.org/10.7570/jomes23031
  4. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020;21:300-7.e2. https://doi.org/10.1016/j.jamda.2019.12.012
  5. Lee A, Kim YJ, Oh SW, et al. Cut-off values for visceral fat area identifying Korean adults at risk for metabolic syndrome. Korean J Fam Med 2018;39:239-46. https://doi.org/10.4082/kjfm.17.0099
  6. Kim EH, Kim HK, Lee MJ, et al. Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus. Diabetes Metab J 2022;46:486-98. https://doi.org/10.4093/dmj.2021.0095
  7. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-9. https://doi.org/10.1016/0026-0495(87)90063-1
  8. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. Erratum in: Circulation 2005;112:e297. Erratum in: Circulation 2005;112:e298.
  9. Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr 2022;31:169-77. https://doi.org/10.7570/jomes22024
  10. Park D, Shin MJ, Despres JP, Eckel RH, Tuomilehto J, Lim S. 20-year trends in metabolic syndrome among Korean adults from 2001 to 2020. JACC Asia 2023;3:491-502. https://doi.org/10.1016/j.jacasi.2023.02.007
  11. Kang SY, Park HS. Gender differences in comorbidities and attitudes regarding weight control among young adults with obesity in Korea. Obes Facts 2022;15:581-9. https://doi.org/10.1159/000524381
  12. Kim KK, Haam JH, Kim BT, et al. Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr 2023;32:1-24. https://doi.org/10.7570/jomes23016
  13. McCarthy D, Berg A. Weight loss strategies and the risk of skeletal muscle mass loss. Nutrients 2021;13:2473.
  14. Bellicha A, van Baak MA, Battista F, et al. Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies. Obes Rev 2021;22(Suppl 4):e13256.
  15. Papatriantafyllou E, Efthymiou D, Zoumbaneas E, Popescu CA, Vassilopoulou E. Sleep deprivation: effects on weight loss and weight loss maintenance. Nutrients 2022;14:1549.
  16. Cao J, Qiu W, Lin Y, Liu T, Dou Z, Chen Z. Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020. Prev Med Rep 2023;36:102406.
  17. Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) 2012;20:330-42. https://doi.org/10.1038/oby.2011.330
  18. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011;377:1341-52. Erratum in: Lancet 2011;377:1494.
  19. Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SE-QUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012;95:297-308. https://doi.org/10.3945/ajcn.111.024927